ArticleJournal of rheumatic diseases2026
Multifocal tuberculous myositis: a case series from a tuberculosis endemic region.
Article in Journal of rheumatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Multifocal tubercular myositis is rare but important entity that often mimics autoimmune rheumatic or inflammatory muscle diseases. This study aims to collect and analyse cases of multifocal muscular tuberculosis (TB) reported in tertiary care settings in India. Methods: This retrospective, multicentre, observational study was conducted at two tertiary care centres in India between 2019 and 2025. Patients with confirmed TB and evidence of muscle involvement at ≥2 non-contiguous sites were included. Muscle involvement was confirmed by imaging (CT, MRI, ultrasound, FDG-PET) with or without clinical/myopathic features. Clinical, biochemical, radiological, and treatment data were extracted from records. Results: Among 74 patients with musculoskeletal TB, six (8.1%) had multifocal muscle involvement. Median age was 42.5 years, with equal sex distribution. The mean diagnostic delay was 13.4 months. Inflammatory markers were elevated (mean erythrocyte sedimentation rate 51.2 mm/hr, C-reactive protein 93 mg/L), while muscle enzymes were normal or mildly elevated. Only one patient (16.7%) had isolated muscle TB; others had lymph node (66.7%), skeletal (50.0%), or pulmonary involvement (33.3%). Two patients had underlying connective tissue diseases, and three (50.0%) were on immunosuppressive therapy at diagnosis. GeneXpert-PCR had an 83% yield from muscle tissue or pus. Clinical and radiological improvement was noted in all cases, three (50.0%) required concurrent immunosuppression. Conclusion: The consideration of multifocal tubercular myositis in the differential diagnosis of inflammatory myopathies, is paramount to reduce diagnostic delays and improve outcomes. A high index of suspicion, use of advanced imaging, and microbiological confirmation are key to the early diagnosis of this entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.